| Literature DB >> 14757531 |
Sylvie Giuriato1, Karen Rabin, Alice C Fan, Catherine M Shachaf, Dean W Felsher.
Abstract
The ability to model cancer in the mouse has provided a robust methodology to dissect the molecular etiology of cancer. These models serve as potentially powerful platforms to preclinically evaluate novel therapeutics. In particular, the recent development of strategies to conditionally induce the or knockout the function of genes in a tissue specific manner has enabled investigators to engineer mice to demonstrate that the targeted inactivation of specific oncogenes can be effective in inducing sustained regression of tumors. Thus, these animal models will be useful to define the specific genes that will be therapeutically useful to target for the treatment of particular human cancers.Entities:
Mesh:
Year: 2004 PMID: 14757531 DOI: 10.1016/j.semcancer.2003.11.002
Source DB: PubMed Journal: Semin Cancer Biol ISSN: 1044-579X Impact factor: 15.707